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Abstract
Obesity and diabetes are frequently associated with cardiovascular disease. When a normal heart is
subjected to brief/sublethal repetitive ischemia and reperfusion (I/R), adaptive responses are
activated to preserve cardiac structure and function. These responses include but are not limited to
alterations in cardiac metabolism, reduced calcium responsiveness, and induction of antioxidant
enzymes. In a model of ischemic cardiomyopathy inducible by brief repetitive I/R, we
hypothesized that dysregulation of these adaptive responses in diet-induced obese (DIO) mice
would contribute to enhanced myocardial injury. DIO C57BL/6J mice were subjected to 15 min of
daily repetitive I/R while under short-acting anesthesia, a protocol that results in the development
of fibrotic cardiomyopathy. Cardiac lipids and candidate gene expression were analyzed at 3 days,
and histology at 5 days of repetitive I/R. Total free fatty acids (FFAs) in the cardiac extracts of
DIO mice were significantly elevated, reflecting primarily the dietary fatty acid composition.
Compared with lean controls, cardiac fatty acid oxidation capacity of DIO mice was significantly
higher, concurrent with increased expression of fatty acid metabolism gene transcripts. Following
15 min of daily repetitive I/R for 3 or 5 days, DIO mice exhibited increased susceptibility to I/R
and, in contrast to lean mice, developed microinfarction, which was associated with an
exaggerated inflammatory response. Repetitive I/R in DIO mice was associated with more
profound significant downregulation of fatty acid metabolism gene transcripts and elevated FFAs
and triglycerides. Maladaptive metabolic changes of fatty acid metabolism contribute to enhanced
myocardial injury in diet-induced obesity.
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Introduction
Obesity is frequently accompanied by insulin resistance and is associated with metabolic
abnormalities, namely hyperglycemia, increased plasma free fatty acid (FFA)
concentrations, and ectopic accumulation of lipid metabolites in nonadipose tissues such as
skeletal muscle, liver, and heart. There is growing evidence that excessive lipid
accumulation in cardiomyocytes is toxic and contributes significantly to cardiac disorders
commonly associated with obesity and/or diabetes (1).
Fatty acids (FAs) are the preferred substrate for ATP generation in a normal healthy heart
(2), and the rate of FA uptake and oxidation is regulated at multiple levels. The adult heart
has the metabolic capability to switch substrate preferences in various pathological
conditions. When the heart is stressed either physiologically or pathologically, a series of
adaptive responses are normally activated; metabolic remodeling is one of the foremost. In
fact, we have proposed that metabolic remodeling precedes, triggers, and sustains
subsequent functional and structural remodeling (3). A significant characteristic of the
maladapted heart is loss of this metabolic flexibility. Increased reliance on any one
metabolic pathway, along with reduced capacity for substrate switching, has been associated
with accumulation of lipid species in the cardiomyocyte. For example, in diabetes, the heart
almost exclusively relies on FA oxidation (FAO) (4,5), whereas in hypoxic conditions (6)
and hypertrophy (7), glucose utilization increases. Both conditions are associated with lipid
accumulation within cardiomyocytes. Surplus accumulation of lipid species in
cardiomyocytes has been shown to be associated with tissue dysfunction in genetic and
transgenic animal models of obesity and diabetes (8,9). Our recent observation in heart
failure patients with nonischemic disease suggests that intramyocardial lipid deposition is a
feature in diabetic patients with obesity (10). These findings tie in with the long suggested
argument that development and progression of heart failure is related to abnormalities in
myocardial substrate metabolism.
We have previously described a murine model of ischemic cardiomyopathy induced by brief
(15 min) daily repetitive ischemia and reperfusion (I/R), which does not result in myocardial
necrosis but is associated with development of interstitial fibrosis and ventricular
dysfunction (11). Both ventricular dysfunction and cardiac fibrosis are reversible upon
discontinuation of the ischemic protocol. The histological findings in the mouse closely
resembled the pathology of human reversible ischemic cardiomyopathy that is associated
with myocardial hibernation (11,12). Induction of reactive oxygen species (ROS) is a critical
early event that regulates processes such as the expression of the chemokine MCP-1 and
subsequent inflammatory response, fibrosis, and ventricular dysfunction (11). In addition,
ROS regulate mRNA expression of antioxidant enzymes, FA metabolism, and myosin
isoform genes (13). Our previous findings in this model suggest that downregulation of
peroxisome proliferator activated receptor–α (PPAR-α) expression and FAO are elements of
an adaptive response that prevent lipotoxicity in repetitive I/R despite the fact that occlusion
occurs only 15 min/day and is not accompanied by infarction (11,13). Although it is clear
that diet-induced obesity is associated with cardiac lipotoxicity, the role of accumulated lipid
metabolites and metabolic adaptation in repetitive I/R injury has not been described. Obesity
induced by a “Western” high-fat diet in C57BL/6J mice is associated with cardiac metabolic
changes very similar to the diabetic heart, namely, increased expression of FA metabolism
transcripts, increased capacity for FAO, and ectopic lipid accumulation. We hypothesized
that dysregulation of adaptive responses in diet-induced obese (DIO) mice would enhance
susceptibility to brief repetitive I/R.
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Research Methods and Procedures
Animal Care
All animals received humane care in compliance with the “Guide for the Care and Use of
Laboratory Animals” (NIH publication 85–23, revised 1985) and the protocol was approved
by the Institutional Animal Care and Use Committee of Baylor College of Medicine.
C57BL/6J mice (The Jackson Laboratory, ME) were bred in-house. Mice (3–5 per cage)
were allowed ad libitum access to water and a standard chow diet containing ~13.5% kcal
from fat (Picolab Rodent Diet 5010, Purina Mills, Inc, St. Louis, MO) after weaning until 6–
8 weeks of age. Obesity was induced by allowing ad libitum access to a high-fat diet
containing ~42% kcal from fat (Dyet #112734, Research Diets, Inc, New Brunswick, NJ)
starting at age 6–8 weeks for 24 weeks. The lean controls continued to feed on chow diet
until the time of experiment.
Cardiac Fatty Acid Determination by Gas Chromatography–Mass Spectrometry
Methylation of plasma nonesterified FAs were analyzed implementing a method by Lepage
et al (14). Briefly, an internal standard of heptadecanoic acid (17:0) dissolved in methanol-
acetyl chloride 50:1 (v/v) and 150 μl of tissue extract was methylated at 24–29°C for 45 min
on a stir plate. The methylation reaction was stopped with 6% K2CO3 solution and lipids
were extracted with hexane. Following evaporation, the sample was dissolved in 100 μl of
decane and transferred to a small 2-ml vial with a 250-μl insert. Vials were placed in a
Hewlett-Packard 7683 automatic injector. FAs were chromatographed as methyl esters on a
30-m fused silica column with an internal diameter of 0.25 mm. The AT-255 column was
wall-coated with 0.25 μm (50% cyanopropylphenyl)-dimethylpolysiloxan bonded phase
(Alltech, Deerfield, IL). Analysis was performed on a Hewlett-Packard 6890GC coupled to
a 5973 Mass Selective Detector. The machine was operated in the electron impact mode (70
eV) with full scan monitoring. Helium was used as carrier gas (1.0 ml/min) and was set to
splitless mode. After an initial isothermal period of 2 min at 70°C, the temperature was
programmed to 180°C, rising by 20°C/min, then a subsequent increase to 220°C at a rate of
3.0°C/min and maintained for 16 min. Injector and detector temperatures were set to 250°C,
respectively. The gas chromatograph was calibrated using standard mixtures of different
short- and long-chain FAs (Sigma, St. Louis, MO). For quantification, the FA calibration
curves measuring peak area versus that of internal standard were used. Peak identification
was confirmed by relative retention time and mass spectral comparison with authentic
standards, as well as with the NIST standard reference database number 69.
Fatty Acid Oxidation Studies in vitro
The FAO studies were performed in heart homogenates from lean and obese mice by a
protocol described by Sekiguchi et al (15) using [1-14C] palmitic acid. The FA β-oxidation
capacity was expressed as cpm/mg heart tissue.
Lipid Extraction and Triglyceride Determination
Hearts were excised and processed for lipid extraction as described in detail by Thakker et al
(16). Lipids were extracted with chloroform, methanol, and 0.9% sodium chloride according
to the method of Folch (17). Triglycerides were measured with a commercially available kit
(Sigma Diagnostics Inc.) using triolein as the standard.
Brief Repetitive Ischemia–Reperfusion
Lean and DIO mice were instrumented using a closed-chest model of ischemia and
reperfusion as described by Dewald et al (11). Briefly, mice were anesthetized with sodium
pentobarbital (10 μl/gm body weight, Nembutal, Abbott Laboratories, North Chicago, IL).
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Following a midline skin incision and intubation, a left parasternal thoracotomy was
performed between the third and fifth rib. An 8–0 Prolene R (Ethicon, Sommerville, NJ)
suture was placed around the left anterior descending artery, both ends of which were
threaded through a 1-mm piece of PE-10 plastic tube (Beckton Dickinson), exteriorized
through the thorax wall, and stored subcutaneously. The chest and skin were closed and
mice were allowed to recover for 7–9 days. After recovery, mice were anesthetized, the skin
was opened, and the ends of the suture were attached to heavy metal picks. Ischemia was
initiated by pulling apart the picks until an ST elevation of 1 min or greater was observed on
the electrocardiogram. Fifteen minutes of ischemia was followed by reperfusion (resolution
of ST elevation). Mice underwent brief (15 min) episodes of repetitive ischemia for 3 or 5
consecutive days. Sham-operated animals underwent the initial surgery and waited for the
same period of time as I/R groups. Five hours after the last ischemic episode, mice were
anesthetized with an overdose of sodium pentobarbital; the heart was excised, stopped in
diastole by rinsing in cardioplegic solution, perfusion fixed, and paraffin embedded for
histological studies or immersed in TRIzol reagent for RNA extraction.
Histology and Immunohistochemistry
Paraffin-embedded hearts were sectioned at intervals of 200 μm from base to apex. Sections
were stained with hematoxylin and eosin for initial evaluation and identification of the area
below the suture. After the initial evaluation, serial sections were stained with picrosirius red
to identify collagen fibers (18). The picrosirius-stained slides were scanned using a Zeiss
Axioskop microscope, and quantitative evaluation was performed using ImagePro software
as described before (19). Percent collagen staining was assessed in the anterior wall after 5
days of repetitive I/R.
Immunohistochemistry with specific anti-mouse antibody was performed to identify the
following cell types: neutrophils (rat anti-mouse neutrophil antibody, Serotec, Oxford, UK),
and myofibroblasts (monoclonal α–smooth muscle actin antibody, Sigma, St. Louis, MO).
Staining was performed using a peroxidase-based technique with the Vectastain Elite kit
(Vector laboratories, Burlingame, CA). Sections were counterstained with eosin, and
quantitative analysis was performed by counting the density of labeled cells in the anterior
wall after 5 days of repetitive I/R. Myofibroblasts were identified as spindle-shaped α–
smooth muscle actin–positive cells located outside the vascular media and their density was
expressed as cells/mm2.
Gene Expression by Real-Time PCR
The methods for RNA isolation, cDNA synthesis, and quantitive RT-PCR have been
described previously (20). The nucleotide sequence for primers and probes for PPAR-α,
muscle-type carnitine palmitoyltransferase–1 (mCPT-1), and medium-chain acyl–coenzyme
A dehydrogenase (MCAD) have also been published previously (20,21). Taqman primers
and probes for PPAR-β/δ and 18S were obtained from Applied Biosystems. Cyclophilin
transcript levels were determined using SYBR Green chemistry using published primer
sequences (22). Expression was normalized to either 18S or cyclophilin transcript levels.
Internal standards were prepared using T7 RNA polymerase method.
Statistical Analysis
Data are expressed as mean±SEM. Statistical differences between groups were analyzed by
the unpaired Student’s t-test. Data that did not follow normal Gaussian distribution were
analyzed by a nonparametric Mann–Whitney test. A value of P≤0.05 was considered
significant.
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Results
C57BL/6J mice fed a “Western” high-fat diet for 24 weeks became obese and developed
insulin resistance. Male obese mice were approximately 1.5 times heavier than lean male
mice (47.5 gm vs 32.2 gm, P<0.001), while female obese mice were 2-fold heavier than lean
female mice (51.4 gm vs 24.4 gm, P<0.001). Diet-induced obesity was associated with
significantly elevated plasma insulin levels in female (0.88 ng/ml vs 0.33 ng/ml in lean
controls, P<0.05), and male (3.9 ng/ml vs 0.28 ng/ml in lean controls, P<0.01) mice.
Similarly, fasting plasma glucose levels were significantly (P<0.05) elevated in male obese
mice (168 mg/dl) compared with male lean mice (126.2 mg/dL); in the female group no
such difference was noted. As a consequence, HOMA-IR indicated that obese male mice
were severely insulin resistant (16). Table 1 summarizes the FA composition of chow and
“Western” high-fat diets. The “Western” high-fat diet contained markedly higher saturated
FAs, 2 times more unsaturated FAs, and a greater n-3/n-6 ratio than chow diet.
Cardiac Lipids and Fatty Acid Oxidation
Altered cardiac lipid metabolism is frequently associated with lipid accumulation in the
cardiomyocyte. We have previously reported that diet-induced obesity is associated with
modest but significant triglyceride deposition in the heart (16). The total FFA concentration
in the cardiac homogenates was 67% higher in obese (27.59±2.09 ng) than in lean
(16.55±1.67 ng, P<0.01) mice. Analysis of individual FAs by gas chromatography–mass
spectrometry (GC-MS) revealed that the concentrations of C14:0, C16:1, C18:0, C18:1, and
C20:4 were significantly higher in cardiac extracts of obese than lean mice. However, C18:2
level was higher in the hearts of lean than obese mice (Figure 1). To estimate the cardiac
FAO of lean and obese mice, we determined the oxidation of [1-14C] palmitate to its
degradation products in cardiac homogenates. Mean FAO of obese mice was ~30% higher
than lean mice (74.67±4.31 vs 57.84±3.48 cpm/mg heart weight, P<0.05).
Cardiac Gene Expression after Repetitive I/R
To evaluate the consequences of obesity, insulin resistance, and associated cardiac
lipotoxicity in the development of fibrotic cardiomyopathy, gene expression and
histopathology were examined in a model of brief repetitive myocardial I/R. Based on prior
knowledge that ischemia profoundly affects cardiac FA metabolism, cardiac mRNA
expression of PPAR-α and -β/δ, master regulators of FAO were measured after 3 days of
repetitive I/R and compared with respective sham-operated animals (Figure 2). The
transcript levels of PPAR-α and -β/δ in obese sham-operated mice were upregulated ~1.6-
fold compared with lean sham-operated mice. Repetitive I/R protocol significantly
decreased both PPAR-α and -β/δ in obese mice compared with obese sham animals. In lean
animals subjected to repetitive I/R, expression of PPAR-α was not altered, but we did note a
modest and significant increase in the expression of PPAR-β/δ. To determine whether
elevated expression of PPAR-α and -β/δ correlated with increased expression of target genes
involved in FAO, we examined the mRNA expression of two target genes, mCPT-1 and
MCAD, in lean and obese animals after I/R. Obesity was associated with increased
expression of mCPT-1, and there was a trend towards higher expression of MCAD (P=0.08).
As noted above for PPAR-α and -β/δ, repetitive I/R significantly downregulated expression
of mCPT-1 and MCAD in obese but not lean animals (Figure 2).
Cardiac Lipids and Plasma FFAs after Repetitive I/R
To address whether downregulation of FA metabolism genes in obese mice after repetitive I/
R resulted in changes in cardiac lipid profile, we measured lipids after 3 days of repetitive I/
R. The total FFAs remained significantly elevated in obese mice after repetitive I/R
(P<0.001), with significantly higher levels of C16:0, C18:0, C18:1 and C20:4 in obese than
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lean mice. C18:2 and C22:6 levels were higher in lean mice (Figure 3a). In addition, cardiac
triglyceride concentration was significantly elevated in obese mice after I/R (Figure 3b).
Because high levels of FAs are commonly seen after myocardial infarction or following
reperfusion after cardiac surgery in humans, we measured the total plasma FFAs after 3 days
of repetitive I/R. As shown in Figure 3c, the plasma FFAs at 3 days of repetitive I/R were
markedly higher in obese than lean animals.
Histopathology after Repetitive I/R
We have reported previously that short episodes of ischemia lead to reversible ischemic
cardiomyopathy (11). Figures 4 and 5 summarize the histological evaluation in lean and
obese mice after 5 days of repetitive I/R. In lean mice, we noted interstitial widening and
marked fibrosis in the anterior wall with no infarction. However, obese mice reacted
adversely to these brief episodes of I/R and developed microinfarcts. Microinfarction, as
expected, was associated with an increased inflammatory infiltrate. Myofibroblast density
and fibrosis were markedly increased in DIO mice compared with lean mice. Neutrophil
density was also significantly increased in DIO mice (17.43±6.98 cells/mm2) compared with
lean mice (3.67±0.75 cells/mm2; P=0.04).
Discussion
In the present study, we investigated whether cardiac lipotoxicity and metabolic
maladaptation in obesity induced by a high-fat “Western” diet contribute to increased
myocardial susceptibility in a mouse model of ischemic cardiomyopathy, a model exhibiting
pathological features similar to human hibernating myocardium (11,12). The main findings
of our study are [1] insulin-resistant diet-induced obese mice display elevated levels of lipid
species in the heart along with altered mRNA expression of genes regulating myocardial
FAO, [2] obesity is associated with increased myocardial susceptibility to repetitive I/R
manifested as microinfarction with enhanced fibrosis, and [3] repetitive I/R in obese mice is
associated with early and more profound downregulation of myocardial FAO-regulating
genes and elevated lipids in the heart. The mouse model of diet-induced obesity used in this
study develops hyperinsulinemia and insulin resistance with significantly elevated levels of
FFAs in the plasma compared with lean mice (16). Although blood pressure and cardiac
indices are similar in lean and obese mice, diet-induced obesity is associated with
development of cardiac hypertrophy. Moreover, cardiac collagen content as measured by
picrosirius staining was similar between lean and obese mice (16).
Cardiac Lipotoxicity in DIO Mice
A significant marker indicative of cardiac lipotoxicity is ectopic accumulation of triglyceride
within cardiomyocytes (8). In pathological conditions, this is generally thought to result
from a mismatch between uptake and utilization of FAs, which, in the cardiomyocyte, is
regulated by PPAR-α. It should be noted that triglycerides themselves are considered
relatively inert, and toxicity is mainly imparted by surplus long-chain nonesterified FFAs
and their derivatives, ceramides and diacylglycerol. In cell culture studies with normal rat β-
cells, oleate and palmitate induced apoptosis in a dose-dependent manner, while the cellular
triglyceride content was inversely correlated with the percentage of dead cells (23).
Similarly, Listerberger et al. have shown in CHO cells that oleic acid supplementation led to
triglyceride accumulation and was well tolerated, whereas palmitic acid was poorly
incorporated and led to apoptosis (24). Nonetheless, cellular triglycerides do represent a
pool that can be potentially hydrolyzed to liberate toxic free fatty acyl moieties. We have
demonstrated that diet-induced obesity is associated with ~30% increased cardiac
triglyceride accumulation (16). Given that the rate of FA uptake by the heart is primarily
determined by levels of FFAs in the plasma (25,26), and our observation that DIO mice had
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elevated FFAs in the plasma compared with lean mice, we measured nonesterified FAs in
the cardiac extracts of DIO and lean mice. In support of the above paradigm, the
concentration of FFAs in heart extracts of DIO mice was 67% higher than those of lean
mice. Also, the FFA profile in heart extracts of lean and obese mice largely reflected the FA
composition of the diet. In particular, levels of arachidonic acid (n-6), a proinflammatory
FA, were significantly higher, whereas levels of DHA, which is known to exert
cardioprotective effects (27), were lower in heart extracts of obese mice. Palmitic acid
levels, a saturated FA that induces apoptosis in cardiomyocytes (28), were ~7-fold higher in
cardiac extracts of obese mice compared with lean mice. From a nutritional perspective, the
FA composition of the high-fat diet used in our study has been associated with adverse
cardiovascular outcomes in humans.
PPAR-α and -β/δ are the principal regulators of long-chain FA metabolism in the heart and
regulate genes involved in virtually every step of cardiac long-chain FA utilization (29). We
analyzed cardiac expression of PPAR-α and -β/δ, and found their expression to be
significantly upregulated in DIO mice compared with lean mice. Moreover, mRNA
expression of mCPT-1 and MCAD, enzymes whose expression is inducible by PPAR-α and
-β/δ, were upregulated in DIO mice. We also found that in DIO mice, increased expression
of FA metabolism gene transcripts was accompanied by increased capacity for
mitochondrial FAO. Despite the increased expression of FA metabolism genes and capacity
for metabolism, obesity was associated with triglyceride accumulation in the heart,
suggesting that the tightly regulated process of FA uptake and utilization was perturbed in
DIO mice.
Myocardial Susceptibility to Repetitive I/R
In the ischemic cardiomyopathy model used in this study, we have shown previously that
daily episodes of brief I/R resulted in ROS-dependent upregulation of MCP-1 that was
followed by infiltration of phenotypically modified α–smooth muscle actin–positive
myofibroblasts and macrophages. Brief repetitive I/R episodes led to reversible interstitial
fibrosis and ventricular dysfunction in the absence of myocardial infarction and necrosis
(11,30). . Furthermore, expression of metabolic and myosin isoform genes was altered, again
in a ROS-dependent pattern. The pathology characteristic of repetitive I/R was prevented in
transgenic mice overexpressing superoxide dismutase (11).. The infarction model, in
contrast, is attended by acute chemokine and cytokine induction, a robust inflammatory
response, and clearing of dead necrotic tissue that is eventually replaced with a collagen-
based scar. . In the present study, the histology in lean mice after 5 days of repetitive I/R was
similar to what we reported earlier (11): interstitial fibrosis was associated with infiltrating
myofibroblasts and macrophages in the absence of cardiomyocyte death and necrosis. In
contrast, after 5 days of repetitive I/R in obese mice, we observed microinfarcts in the
anterior wall, suggesting enhanced myocardial susceptibility to brief episodes of I/R. Not
surprisingly, microinfarction in obese mice was associated with significantly increased
fibrosis in the anterior wall. The density of myofibroblasts, cells critical for progression of
fibrosis because of their ability to secrete procollagen, was also significantly increased in the
anterior wall of obese compared with lean mice.
Metabolic Maladaptation to Repetitive I/R in DIO Mice
Studies in animal models have shown that the adult heart responds to stress triggers such as
pressure overload, hypertension, and myocardial infarction by structural remodeling that is
accompanied by a switch to the fetal gene program (31). Most notably, to improve cardiac
efficiency, the heart switches from fatty acid metabolism to oxidation of more efficient
substrates such as glycogen, lactate, and glucose (32,33) . In the present study, after 3 days
of repetitive I/R, expression of transcripts regulating cardiac FA metabolism was
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significantly different in lean and obese groups. When studied at 3 days, PPAR-α and its
target genes mCPT-1 and MCAD were significantly downregulated in obese animals
exposed to repetitive I/R compared with sham animals, whereas in the lean group expression
of these genes was not significantly altered. Expression of PPAR-β/δ, an equally important
regulator of cardiac FA metabolism, was significantly increased in lean mice subjected to
repetitive I/R compared with sham animals. In contrast, PPAR-β/δ expression was
downregulated after repetitive I/R in obese mice. We previously demonstrated in a time
course study of wild-type lean C57BL/6J mice that expression of PPAR-α and its target
genes was significantly altered only at 7 days of repetitive I/R in a ROS-dependent manner
(13). Reactivation of PPAR-α in these lean mice was associated with increased cellular
injury. Thus, downregulation of PPAR-α in repetitive I/R may be an adaptive mechanism to
prevent lipotoxicity in the ischemic myocardium. In the current study, downregulation of
PPAR-α and -β/δ and their target genes at 3 days of repetitive I/R indicates that the
metabolism switches from FAO much earlier in the obese mice. At the same time, obese
mice had significantly elevated plasma FFAs compared with lean mice, likely because they
continue to feed on their respective diets. Furthermore, cardiac FFAs and triglycerides were
higher in obese compared with lean mice exposed to repetitive I/R. We propose that the
adaptive response of downregulating FAO machinery to prevent lipotoxic injury caused by
repetitive I/R becomes maladaptive in obese insulin-resistant mice when cardiac supply of
FFAs exceeds FAO. Unmetabolized FFAs are capable of inflicting cellular damage through
mechanisms such as induction of apoptosis by palmitic acid (34), and activation of cytokines
and inflammatory pathways via activation of NF-κB–regulated genes (35). At the cellular
level, excess saturated FFAs may be directed to nonoxidative pathways that promote
synthesis of ceramide (36), a sphingolipid that can activate JNK, p38, and IκB kinase (37),
thereby activating pathways that lead to both inflammation and development of tissue-
specific insulin resistance (38).
In summary, we show that obesity induced by a “Western” high-fat diet is associated with
cardiac lipid accumulation and alterations in FA metabolism in the heart, indicative of
cardiac lipotoxicity. Activation of adaptive mechanisms in response to stress is an inherent
feature of the heart and preserves structure and function. Our studies indicate that repetitive
I/R–induced adaptive mechanisms are severely impaired in DIO mice and contribute to
increased myocardial injury. Because of the experimental design of these studies, we are not
able to determine how much of the observed increase in myocardial susceptibility to
repetitive ischemia was due to the effects of high–saturated fat “Western” diet versus
obesity. However, future studies can target selected interventions on diet and obesity to
determine the optimal strategy to reduce myocardial susceptibility to repetitive ischemia.
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Figure 1.
Long-chain free fatty acids (FFAs) in cardiac extracts of diet-induced obese (DIO) mice
were significantly elevated. Levels of C14:0, C16:1, C18:0, C18:1, and C20:4 as measured
by GC-MS were significantly higher in obese than lean mice, whereas C18:2 and C22:6
levels were higher in lean compared with obese heart extracts n=4 each).
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Figure 2.
Diet-induced obesity alters cardiac fatty acid metabolism gene expression. The transcript
levels of PPAR-α, PPAR-β/δ, and their target gene mCPT-1 were significantly upregulated
in obese (n=3) compared with lean sham animals (n=4). Transcript levels of MCAD tended
(P=0.08) to be higher in obese compared with lean sham-operated animals. Repetitve I/R at
3 days was associated with significant downregulation of PPAR-α, mCPT-1, and MCAD
transcripts in obese mice (n=8) but not in lean mice (n=9) compared with respective shams.
PPAR-β/δ was significantly upregulated in lean repetitive I/R animals but was
downregulated in obese repetitive I/R animals compared with respective shams..
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Figure 3.
Cardiac FFAs, triglycerides, and circulating FFAs after 3 days of repetitive I/R. Cardiac
levels of the FFAs C16:1, C18:0, C18:1, and C20:4 (A) and triglycerides (B) were
significantly higher in obese than lean mice, whereas C18:2 and C22:6 (A) were higher in
obese mice. Circulating FFAs (C) after 3 days of repetitive I/R were markedly higher in
obese than lean mice.
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Figure 4.
Increased myofibroblast density in obese mice after 5 days of repetitive I/R. Cardiac
myofibroblasts were identified as spindle-shaped α–smooth muscle actin–positive cells
located outside the media of vessels (arrows). α–smooth muscle actin
immunohistochemistry also stained vascular smooth muscle cells (arrowheads).
Myofibroblast density (A) was markedly higher in obese (n=7) than lean (n=9) mice. A
nonparametric Mann–Whitney test was used to compare groups (P=0.04). A representative
image of the anterior wall of lean and obese mice depicts myofibroblasts (B).
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Figure 5.
Obese mice had increased fibrosis associated with microinfarction after 5 days of repetitive
I/R. Collagen was detected by picrosirius staining and quantitated in the anterior wall of lean
(n=9) and obese (n=7) mice. Lean mice exhibited extensive interstitial fibrosis (arrows) in
the absence of significant cardiomyocyte loss. In contrast, obese mice had microinfarction
accompanied by replacement fibrosis (arrows) and markedly enhanced collagen deposition
(p<0.01).
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Table 1
Fatty acid composition of diets
Fatty acid Chow diet High-fat diet
C4:0 — 0.71
C6:0 0.01 0.42
C8:0 0.01 0.25
C10:0 0.01 0.57
C12:0 0.01 0.63
C14:0 0.09 2.25
C14:1 (n-9) 0.01 0.34
C16:0 0.90 5.88
C16:1 (n-9) 0.13 0.53
C18:0 0.26 2.73
C18:1 (n-9) 1.10 5.63
C18:2 (n-6) 1.88 0.53
C18:3 (n-3) 0.17 0.32
C20:0 0.01 0.23
C20:4 (n-6) 0.01 —
20:1 (n-9) 0.02 —
20:2 (n-6) 0.01 —
20:5 (n-3) 0.10 —
22:6 (n-3) 0.11 —
22:5 (n-3) 0.02 —
saturated 1.28 13.67
unsaturated 3.55 7.33
n-6 1.90 0.53
n-3 0.39 0.32
n-3/n-6 ratio 0.20 0.60
Values represent weight percent of total fatty acids in dietary lipids.
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